Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells

Embryonic stem (ES) cells, the totipotent outgrowths of bias-tocysts1,2, can be cultured and manipulated in vitro and then returned to the embryonic environment where they develop normally and can contribute to all cell lineages3–9. Maintenance of the stem-cell phenotype in vitro requires the presence of a feeder layer of fibroblasts1,2,10 or of a soluble factor, differentiation inhibitory activity (DIA) produced by a number of sources5,11,12; in the absence of DIA the ES cells differentiate into a wide variety of cell types. We recently noted several similarities between partially purified DIA and a haemopoietic regulator, myeloid leukaemia inhibitory factor (LIF), a molecule which induces differentiation in Ml myeloid leukaemic cells and which we have recently purified, cloned and characterized13–18. We demonstrate here that purified, recombinant LIF can substitute for DIA in the maintenance of totipotent ES cell lines that retain the potential to form chimaeric mice.

[1]  D. Hilton,et al.  Purification of a murine leukemia inhibitory factor from Krebs ascites cells. , 1988, Analytical biochemistry.

[2]  D. Hilton,et al.  Structural characterization of a murine myeloid leukaemia inhibitory factor. , 1988, European journal of biochemistry.

[3]  D. Hilton,et al.  Specific binding of murine leukemia inhibitory factor to normal and leukemic monocytic cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Smith,et al.  Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. , 1987, Developmental biology.

[5]  A R Rees,et al.  Three distinct epitopes within the loop region of hen egg lysozyme defined with monoclonal antibodies. , 1985, The EMBO journal.

[6]  A. Kelso,et al.  Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). , 1987, The EMBO journal.

[7]  T. Doetschman,et al.  Transgenesis by means of blastocyst-derived embryonic stem cell lines. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R Kemler,et al.  The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. , 1985, Journal of embryology and experimental morphology.

[9]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[10]  D. Hilton,et al.  Resolution and purification of three distinct factors produced by Krebs ascites cells which have differentiation-inducing activity on murine myeloid leukemic cell lines. , 1988, The Journal of biological chemistry.

[11]  G. Martin,et al.  Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Monk,et al.  HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells , 1987, Nature.

[13]  M. Evans,et al.  Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[14]  G. Keller,et al.  Gene transfer into murine stem cells and mice using retroviral vectors. , 1985, Cold Spring Harbor symposia on quantitative biology.

[15]  E. Wagner,et al.  Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene , 1988, Cell.

[16]  R. Cotton,et al.  A factor produced by feeder cells which inhibits embryonal carcinoma cell differentiation. Characterization and partial purification. , 1984, Experimental cell research.

[17]  A. Bradley,et al.  A potential animal model for Lesch–Nyhan syndrome through introduction of HPRT mutations into mice , 1987, Nature.

[18]  E. Wagner,et al.  Expression of foreign genes from retroviral vectors in mouse teratocarcinoma chimaeras. , 1985, The EMBO journal.

[19]  M. Capecchi,et al.  Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells , 1987, Cell.

[20]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[21]  E. Robertson.  Teratocarcinomas and embryonic stem cells : a practical approach , 1987 .

[22]  A. Bradley,et al.  Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines , 1984, Nature.

[23]  N. Nicola,et al.  Binding of 125I‐labeled granulocyte colony‐stimulating factor to normal murine hemopoietic cells , 1985, Journal of cellular physiology.

[24]  D. Hilton,et al.  Molecular cloning and expression of the human homologue of the murine gene encoding myeloid leukemia-inhibitory factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Hilton,et al.  Clonal analysis of the actions of the murine leukemia inhibitory factor on leukemic and normal murine hemopoietic cells. , 1988, Leukemia.

[26]  D. Martin,et al.  Mosaic mice with teratocarcinoma-derived mutant cells deficient in hypoxanthine phosphoribosyltransferase. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[27]  John K. Heath,et al.  Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides , 1988, Nature.

[28]  D. Smith,et al.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. , 1988, Gene.

[29]  A. Bradley,et al.  Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector , 1986, Nature.

[30]  David W. Melton,et al.  Targetted correction of a mutant HPRT gene in mouse embryonic stem cells , 1987, Nature.